Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
46.9M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
50.9M
-
Shares change
-
-808K
-
Total reported value, excl. options
-
$943M
-
Value change
-
-$19.4M
-
Put/Call ratio
-
0.31
-
Number of buys
-
86
-
Number of sells
-
-100
-
Price
-
$18.53
Significant Holders of Core Laboratories Inc. /DE/ - Common Shares (CLB) as of Q3 2024
222 filings reported holding CLB - Core Laboratories Inc. /DE/ - Common Shares as of Q3 2024.
Core Laboratories Inc. /DE/ - Common Shares (CLB) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.9M shares
.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (10M shares), BlackRock, Inc. (7.78M shares), DISCIPLINED GROWTH INVESTORS INC /MN (5.65M shares), VANGUARD GROUP INC (5.62M shares), EARNEST PARTNERS LLC (3.76M shares), STATE STREET CORP (1.98M shares), T. Rowe Price Investment Management, Inc. (1.11M shares), GEODE CAPITAL MANAGEMENT, LLC (1.05M shares), ROYCE & ASSOCIATES LP (1.02M shares), and MORGAN STANLEY (1.01M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.